These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31989755)

  • 21. Screening procedure for 38 fentanyl analogues and five other new opioids in whole blood by liquid chromatography-tandem mass spectrometry.
    Adamowicz P; Bakhmut Z; Mikolajczyk A
    J Appl Toxicol; 2020 Aug; 40(8):1033-1046. PubMed ID: 32103530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of the fentanyl analog screening kit toward the identification of emerging synthetic opioids in human plasma and urine by LC-QTOF.
    Krajewski LC; Swanson KD; Bragg WA; Shaner RL; Seymour C; Carter MD; Hamelin EI; Johnson RC
    Toxicol Lett; 2020 Mar; 320():87-94. PubMed ID: 31812604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of fentanyl derivatives at trace levels with nonaqueous capillary electrophoresis-electrospray-tandem mass spectrometry (MS(n), n = 2, 3): analytical method and forensic applications.
    Rittgen J; Pütz M; Zimmermann R
    Electrophoresis; 2012 Jun; 33(11):1595-605. PubMed ID: 22736362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Confirmation of Carfentanil, U-47700 and Other Synthetic Opioids in a Human Performance Case by LC-MS-MS.
    Seither J; Reidy L
    J Anal Toxicol; 2017 Jul; 41(6):493-497. PubMed ID: 28830119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of portable gas chromatography-mass spectrometry (GC-MS) for the analysis of fentanyl, fentanyl analogs, and other synthetic opioids.
    Leary PE; Kizzire KL; Chan Chao R; Niedziejko M; Martineau N; Kammrath BW
    J Forensic Sci; 2023 Sep; 68(5):1601-1614. PubMed ID: 37470264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Data-independent screening method for 14 fentanyl analogs in whole blood and oral fluid using LC-QTOF-MS.
    Palmquist KB; Swortwood MJ
    Forensic Sci Int; 2019 Apr; 297():189-197. PubMed ID: 30802648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The analytical challenges of cyclopropylfentanyl and crotonylfentanyl: An approach for toxicological analysis.
    Maher S; Elliott SP; George S
    Drug Test Anal; 2018 Sep; 10(9):1483-1487. PubMed ID: 29803198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards compound identification of synthetic opioids in nontargeted screening using machine learning techniques.
    Klingberg J; Cawley A; Shimmon R; Fu S
    Drug Test Anal; 2021 May; 13(5):990-1000. PubMed ID: 33207086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of fentanyl and fentanyl analogues in biological samples using liquid chromatography-high resolution mass spectrometry.
    Rab E; Flanagan RJ; Hudson S
    Forensic Sci Int; 2019 Jul; 300():13-18. PubMed ID: 31063883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of buprenorphine, fentanyl and LSD in whole blood by UPLC-MS-MS.
    Berg T; Jørgenrud B; Strand DH
    J Anal Toxicol; 2013 Apr; 37(3):159-65. PubMed ID: 23423312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of a validated UHPLC-MS/MS method for 28 fentanyl-analogue and novel synthetic opioids in whole blood in authentic forensic cases.
    Qin N; Xiang P; Shen B; Zhuo X; Shi Y; Song F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():82-99. PubMed ID: 31177051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and differentiation of cyclopropylfentanyl from E-crotonylfentanyl, Z-crotonylfentanyl, and 3-butenylfentanyl.
    Mallette JR; Casale JF; Hays PA
    Sci Justice; 2019 Jan; 59(1):67-74. PubMed ID: 30654970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro pharmacology of fentanyl analogs at the human mu opioid receptor and their spectroscopic analysis.
    Hassanien SH; Bassman JR; Perrien Naccarato CM; Twarozynski JJ; Traynor JR; Iula DM; Anand JP
    Drug Test Anal; 2020 Aug; 12(8):1212-1221. PubMed ID: 32415719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An interlaboratory study to evaluate the utility of gas chromatography-mass spectrometry and gas chromatography-infrared spectroscopy spectral libraries in the forensic analysis of fentanyl-related substances.
    Ferguson K; Perr J; Tupik S; Gilbert M; Newman R; Winokur A; Vallejo I; Hokanson S; Pothier M; Knapp B; Icard M; Kramer K; Almirall J
    J Forensic Sci; 2023 Sep; 68(5):1504-1519. PubMed ID: 37310108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of pain management drugs, specifically fentanyl, in hair: application to forensic specimens.
    Moore C; Marinetti L; Coulter C; Crompton K
    Forensic Sci Int; 2008 Mar; 176(1):47-50. PubMed ID: 18006260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metonitazene in the United States-Forensic toxicology assessment of a potent new synthetic opioid using liquid chromatography mass spectrometry.
    Krotulski AJ; Papsun DM; Walton SE; Logan BK
    Drug Test Anal; 2021 Oct; 13(10):1697-1711. PubMed ID: 34137194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gas Chromatography-Mass Spectrometry Analysis of Synthetic Opioids Belonging to the Fentanyl Class: A Review.
    Valdez CA
    Crit Rev Anal Chem; 2022; 52(8):1938-1968. PubMed ID: 34053394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of a screening method for fentanyl and its analogues using UHPLC-QTOF-MS with data-independent acquisition (DIA) in MS
    Noble C; Weihe Dalsgaard P; Stybe Johansen S; Linnet K
    Drug Test Anal; 2018 Apr; 10(4):651-662. PubMed ID: 28834382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of vapor profiles of fentalogs and illicit fentanyl.
    Vaughan SR; Fulton AC; DeGreeff LE
    Anal Bioanal Chem; 2021 Nov; 413(28):7055-7062. PubMed ID: 34746963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review.
    Armenian P; Vo KT; Barr-Walker J; Lynch KL
    Neuropharmacology; 2018 May; 134(Pt A):121-132. PubMed ID: 29042317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.